Literature DB >> 29687854

Plasma long non-coding RNAs (lncRNAs) serve as potential biomarkers for predicting breast cancer.

Z-Y Jiao1, Q Tian, N Li, H-B Wang, K-Z Li.   

Abstract

OBJECTIVE: Recent studies have suggested that lncRNAs play important regulatory roles in occurrence and progression of many cancers including breast cancer. However, only a small number of lncRNAs have proved to be related to breast cancer. Moreover, the effect of lncRNAs on breast cancer is yet unclear. We aimed at examining whether the expression level of these lncRNAs in our breast cancer patients could be different to normal people, and whether these lncRNAs could serve as potential biomarkers for the diagnosis of breast cancer. PATIENTS AND METHODS: We selected twelve lncRNAs as the research targets, which were previously found to be abnormally expressed in plasma of other cancers. The expression levels of these lncRNAs were measured by Quantitative Real-time Polymerase Chain Reaction (qRT-PCR) and compared between breast cancer patients and normal people.
RESULTS: The expression levels of plasma lncRNAs (H19, HOTAIR, and RP11-445H22.4) are found to increase significantly in breast cancer patients. The expression levels of other 9 lncRNAs were no significant changed compared with normal people.
CONCLUSIONS: lncRNAs may be related to the occurrence of breast cancer and serve as potential biomarkers for its diagnosis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29687854     DOI: 10.26355/eurrev_201804_14727

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  9 in total

1.  Increased level of long non coding RNA H19 is correlated with the downregulation of miR-326 and BCL-2 genes in pediatric acute lymphoblastic leukemia, a possible hallmark for leukemogenesis.

Authors:  Mahtab Mofidi; Soheila Rahgozar; Shahrzad Pouyanrad
Journal:  Mol Biol Rep       Date:  2021-02-12       Impact factor: 2.316

2.  Blocking lncRNA H19-miR-19a-Id2 axis attenuates hypoxia/ischemia induced neuronal injury.

Authors:  Zhipeng Xiao; Yongming Qiu; Yingying Lin; Rogelio Medina; Sophie Zhuang; Jared S Rosenblum; Jing Cui; Zezhi Li; Xiaohua Zhang; Liemei Guo
Journal:  Aging (Albany NY)       Date:  2019-06-05       Impact factor: 5.682

3.  Interplay of lncRNA H19/miR-675 and lncRNA NEAT1/miR-204 in breast cancer.

Authors:  Volkmar Müller; Leticia Oliveira-Ferrer; Bettina Steinbach; Klaus Pantel; Heidi Schwarzenbach
Journal:  Mol Oncol       Date:  2019-03-14       Impact factor: 6.603

Review 4.  Long Non-Coding RNA in the Pathogenesis of Cancers.

Authors:  Yujing Chi; Di Wang; Junpei Wang; Weidong Yu; Jichun Yang
Journal:  Cells       Date:  2019-09-01       Impact factor: 6.600

5.  Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis.

Authors:  Chunyu Zhang; Haitao Liu; Pengfei Xu; Yinqiu Tan; Yang Xu; Long Wang; Baohui Liu; Qianxue Chen; Daofeng Tian
Journal:  BMC Cancer       Date:  2021-03-09       Impact factor: 4.430

Review 6.  MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review.

Authors:  Simona Ruxandra Volovat; Constantin Volovat; Irina Hordila; Dorin-Alexandru Hordila; Ciprian Camil Mirestean; Oana Tatiana Miron; Cristian Lungulescu; Dragos Viorel Scripcariu; Cati Raluca Stolniceanu; Assia Adrianova Konsoulova-Kirova; Cristina Grigorescu; Cipriana Stefanescu; Cristian Constantin Volovat; Iolanda Augustin
Journal:  Front Oncol       Date:  2020-11-20       Impact factor: 6.244

Review 7.  Current Knowledge of Long Non-Coding RNA HOTAIR in Breast Cancer Progression and Its Application.

Authors:  Yubo Shi; Qingyun Huang; Xinyu Kong; Ruichen Zhao; Xinyue Chen; Yujia Zhai; Lixia Xiong
Journal:  Life (Basel)       Date:  2021-05-26

Review 8.  The role of long non-coding RNA H19 in breast cancer.

Authors:  Ji Wang; Jinyu Sun; Fen Yang
Journal:  Oncol Lett       Date:  2019-11-14       Impact factor: 2.967

9.  Circulating lncRNA UCA1 and lncRNA PGM5-AS1 act as potential diagnostic biomarkers for early-stage colorectal cancer.

Authors:  Minghui Wang; Zhijun Zhang; Deng Pan; Zhigang Xin; Fan Bu; Yue Zhang; Qingwu Tian; Xiaodong Feng
Journal:  Biosci Rep       Date:  2021-07-30       Impact factor: 3.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.